Share Price and Basic Stock Data
Last Updated: February 12, 2026, 9:20 pm
| PEG Ratio | 30.96 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
S H Kelkar & Company Ltd (SHK), operating in the chemicals sector, reported a significant revenue trajectory, with sales rising from ₹1,564 Cr in FY 2022 to ₹1,687 Cr in FY 2023. This upward trend continued into FY 2024 with revenues reaching ₹1,841 Cr, and the trailing twelve months (TTM) figure stood at ₹2,245 Cr. The quarterly sales figures indicate a robust performance, with the latest quarter (Sep 2023) recording sales of ₹455.44 Cr, reflecting a healthy year-on-year growth. The company’s revenue from operations per share for FY 2025 stood at ₹153.40, up from ₹139.43 in FY 2024. This growth trajectory can be attributed to SHK’s focus on innovation and expansion in its product offerings, positioning it well within a competitive landscape that typically sees growth rates ranging from 5% to 10% annually in the chemicals sector.
Profitability and Efficiency Metrics
SHK’s profitability metrics indicate a mixed performance in recent quarters. The operating profit margin (OPM) fluctuated, peaking at 17.44% in Mar 2024 before declining to 9.46% by Sep 2025. The net profit reported for FY 2025 was ₹73 Cr, reflecting a decrease from ₹124 Cr in FY 2024, driven by higher expenses and interest costs. The interest coverage ratio (ICR) stood at a healthy 6.49x, which suggests that the company effectively manages its debt obligations. However, the return on equity (ROE) was recorded at 7.70%, which is relatively low compared to industry averages, indicating room for improvement in generating returns on shareholders’ equity. The company’s cash conversion cycle (CCC) was reported at 187 days, suggesting efficiency challenges in managing working capital compared to industry standards.
Balance Sheet Strength and Financial Ratios
As of the latest reporting period, SHK’s balance sheet reflects a market capitalization of ₹2,416 Cr and total borrowings of ₹889 Cr, resulting in a total debt-to-equity ratio of 0.58, which is manageable within the chemicals sector. The company reported reserves amounting to ₹1,191 Cr, indicating a solid equity base. The price-to-book value (P/BV) ratio stood at 1.93x, suggesting that the stock is trading at a premium relative to its book value, which is indicative of investor confidence. The company’s current ratio was recorded at 1.39, showing a healthy liquidity position, while the quick ratio of 0.75 indicates potential liquidity constraints in covering short-term obligations. The depreciation expense has been steadily increasing, reflecting ongoing investments in fixed assets, which totaled ₹953 Cr as of Mar 2025.
Shareholding Pattern and Investor Confidence
SHK’s shareholding pattern shows a stable promoter holding of 54.87% as of Sep 2025, indicating a strong commitment from the founding entities. Foreign institutional investors (FIIs) held 7.36%, a slight decrease from previous periods, while domestic institutional investors (DIIs) accounted for 5.69%. The public shareholding stood at 32.08%, reflecting a diverse investor base. The number of shareholders increased to 50,971, suggesting growing interest in the company. However, the gradual decline in promoter holding from 58.95% in Jun 2023 to the current level may raise concerns among investors regarding potential dilution of control. The consistent dividend payout ratio of 14.17% for FY 2025 further demonstrates the company’s commitment to returning value to shareholders, despite its recent profitability challenges.
Outlook, Risks, and Final Insight
Looking ahead, SHK faces both opportunities and challenges. The company’s focus on innovation and expansion could drive future revenue growth, especially in a sector poised for recovery. However, risks persist, including volatile raw material prices and increasing competition, which could pressure profit margins. Additionally, the fluctuating net profit and declining OPM raise concerns about operational efficiency. The company must enhance its cost management strategies to sustain profitability and improve ROE. If SHK successfully navigates these challenges while capitalizing on growth opportunities, it could enhance shareholder value significantly. Conversely, failure to address operational inefficiencies and manage external pressures may hinder its growth trajectory, impacting investor sentiment negatively.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Diamines & Chemicals Ltd | 237 Cr. | 243 | 458/227 | 158 | 0.41 % | 3.33 % | 1.78 % | 10.0 | |
| Deco-Mica Ltd | 26.9 Cr. | 64.0 | 90.0/53.0 | 17.7 | 64.2 | 0.00 % | 11.8 % | 7.51 % | 10.0 |
| Andhra Sugars Ltd | 1,014 Cr. | 74.9 | 88.0/63.3 | 10.0 | 121 | 1.07 % | 3.54 % | 2.51 % | 2.00 |
| Tamil Nadu Petro Products Ltd | 849 Cr. | 94.5 | 130/63.6 | 7.89 | 109 | 1.27 % | 6.97 % | 5.10 % | 10.0 |
| SRF Ltd | 84,236 Cr. | 2,842 | 3,325/2,570 | 45.6 | 447 | 0.32 % | 12.3 % | 10.4 % | 10.0 |
| Industry Average | 14,217.44 Cr | 1,208.60 | 31.28 | 204.33 | 0.44% | 10.57% | 8.89% | 7.60 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 414.18 | 384.90 | 472.43 | 422.56 | 455.44 | 471.68 | 513.34 | 470.31 | 542.50 | 543.21 | 567.38 | 580.63 | 553.89 |
| Expenses | 362.52 | 341.46 | 405.18 | 354.61 | 383.81 | 395.82 | 423.80 | 392.05 | 462.38 | 479.56 | 493.95 | 507.62 | 501.50 |
| Operating Profit | 51.66 | 43.44 | 67.25 | 67.95 | 71.63 | 75.86 | 89.54 | 78.26 | 80.12 | 63.65 | 73.43 | 73.01 | 52.39 |
| OPM % | 12.47% | 11.29% | 14.23% | 16.08% | 15.73% | 16.08% | 17.44% | 16.64% | 14.77% | 11.72% | 12.94% | 12.57% | 9.46% |
| Other Income | 8.99 | 1.53 | -20.44 | 1.62 | 1.80 | 1.90 | -0.18 | -120.29 | 20.65 | 0.89 | 61.15 | 3.04 | 1.06 |
| Interest | 5.08 | 6.35 | 7.47 | 9.82 | 9.95 | 10.35 | 10.04 | 9.89 | 12.82 | 13.82 | 12.89 | 13.07 | 13.91 |
| Depreciation | 20.42 | 19.72 | 20.52 | 20.85 | 22.31 | 21.68 | 22.03 | 22.49 | 24.18 | 23.35 | 24.68 | 26.37 | 27.38 |
| Profit before tax | 35.15 | 18.90 | 18.82 | 38.90 | 41.17 | 45.73 | 57.29 | -74.41 | 63.77 | 27.37 | 97.01 | 36.61 | 12.16 |
| Tax % | 28.22% | 29.31% | 94.00% | 28.46% | 26.74% | 29.74% | 41.65% | 16.68% | 37.57% | 36.02% | -5.67% | 30.21% | 24.59% |
| Net Profit | 25.23 | 13.36 | 1.13 | 27.83 | 30.16 | 32.13 | 33.43 | -86.82 | 39.81 | 17.51 | 102.51 | 25.55 | 9.17 |
| EPS in Rs | 1.75 | 0.94 | 0.17 | 1.96 | 2.12 | 2.33 | 2.45 | -6.25 | 2.87 | 1.27 | 7.41 | 1.85 | 0.66 |
Last Updated: December 29, 2025, 7:36 am
Below is a detailed analysis of the quarterly data for S H Kelkar & Company Ltd (SHK) based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 553.89 Cr.. The value appears to be declining and may need further review. It has decreased from 580.63 Cr. (Jun 2025) to 553.89 Cr., marking a decrease of 26.74 Cr..
- For Expenses, as of Sep 2025, the value is 501.50 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 507.62 Cr. (Jun 2025) to 501.50 Cr., marking a decrease of 6.12 Cr..
- For Operating Profit, as of Sep 2025, the value is 52.39 Cr.. The value appears to be declining and may need further review. It has decreased from 73.01 Cr. (Jun 2025) to 52.39 Cr., marking a decrease of 20.62 Cr..
- For OPM %, as of Sep 2025, the value is 9.46%. The value appears to be declining and may need further review. It has decreased from 12.57% (Jun 2025) to 9.46%, marking a decrease of 3.11%.
- For Other Income, as of Sep 2025, the value is 1.06 Cr.. The value appears to be declining and may need further review. It has decreased from 3.04 Cr. (Jun 2025) to 1.06 Cr., marking a decrease of 1.98 Cr..
- For Interest, as of Sep 2025, the value is 13.91 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 13.07 Cr. (Jun 2025) to 13.91 Cr., marking an increase of 0.84 Cr..
- For Depreciation, as of Sep 2025, the value is 27.38 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 26.37 Cr. (Jun 2025) to 27.38 Cr., marking an increase of 1.01 Cr..
- For Profit before tax, as of Sep 2025, the value is 12.16 Cr.. The value appears to be declining and may need further review. It has decreased from 36.61 Cr. (Jun 2025) to 12.16 Cr., marking a decrease of 24.45 Cr..
- For Tax %, as of Sep 2025, the value is 24.59%. The value appears to be improving (decreasing) as expected. It has decreased from 30.21% (Jun 2025) to 24.59%, marking a decrease of 5.62%.
- For Net Profit, as of Sep 2025, the value is 9.17 Cr.. The value appears to be declining and may need further review. It has decreased from 25.55 Cr. (Jun 2025) to 9.17 Cr., marking a decrease of 16.38 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.66. The value appears to be declining and may need further review. It has decreased from 1.85 (Jun 2025) to 0.66, marking a decrease of 1.19.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:43 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 761 | 834 | 925 | 981 | 1,021 | 1,048 | 1,114 | 1,322 | 1,564 | 1,687 | 1,841 | 2,123 | 2,245 |
| Expenses | 628 | 716 | 774 | 814 | 862 | 908 | 955 | 1,083 | 1,350 | 1,469 | 1,537 | 1,828 | 1,983 |
| Operating Profit | 132 | 119 | 151 | 167 | 159 | 141 | 160 | 239 | 215 | 217 | 304 | 296 | 262 |
| OPM % | 17% | 14% | 16% | 17% | 16% | 13% | 14% | 18% | 14% | 13% | 17% | 14% | 12% |
| Other Income | 12 | 25 | 10 | 12 | 13 | 21 | -28 | 36 | 6 | -8 | 5 | -38 | 66 |
| Interest | 18 | 19 | 22 | 6 | 5 | 16 | 26 | 20 | 16 | 24 | 40 | 49 | 54 |
| Depreciation | 19 | 29 | 30 | 19 | 24 | 31 | 52 | 62 | 72 | 80 | 86 | 95 | 102 |
| Profit before tax | 109 | 94 | 110 | 153 | 143 | 115 | 54 | 194 | 132 | 104 | 183 | 114 | 173 |
| Tax % | 27% | 26% | 34% | 31% | 35% | 24% | 34% | 26% | -13% | 40% | 32% | 36% | |
| Net Profit | 79 | 70 | 73 | 105 | 94 | 88 | 36 | 144 | 149 | 63 | 124 | 73 | 155 |
| EPS in Rs | 5,980.35 | 5.32 | 5.05 | 7.25 | 6.49 | 6.12 | 2.53 | 10.24 | 10.73 | 4.42 | 8.84 | 5.29 | 11.19 |
| Dividend Payout % | 19% | 28% | 30% | 24% | 27% | 0% | 38% | 17% | 7% | 45% | 8% | 19% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -11.39% | 4.29% | 43.84% | -10.48% | -6.38% | -59.09% | 300.00% | 3.47% | -57.72% | 96.83% | -41.13% |
| Change in YoY Net Profit Growth (%) | 0.00% | 15.68% | 39.55% | -54.31% | 4.09% | -52.71% | 359.09% | -296.53% | -61.19% | 154.54% | -137.95% |
S H Kelkar & Company Ltd (SHK) has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 14% |
| 3 Years: | 11% |
| TTM: | 17% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 11% |
| 3 Years: | -15% |
| TTM: | 15% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 27% |
| 3 Years: | 21% |
| 1 Year: | 9% |
| Return on Equity | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 11% |
| 3 Years: | 8% |
| Last Year: | 8% |
Last Updated: September 5, 2025, 1:15 pm
Balance Sheet
Last Updated: December 4, 2025, 1:54 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 13 | 132 | 145 | 145 | 145 | 145 | 141 | 141 | 138 | 138 | 138 | 138 | 138 |
| Reserves | 467 | 368 | 571 | 667 | 712 | 719 | 683 | 810 | 875 | 926 | 1,074 | 1,134 | 1,191 |
| Borrowings | 212 | 252 | 85 | 74 | 172 | 342 | 365 | 518 | 698 | 620 | 666 | 832 | 889 |
| Other Liabilities | 169 | 187 | 201 | 187 | 246 | 222 | 277 | 405 | 568 | 518 | 502 | 556 | 587 |
| Total Liabilities | 861 | 939 | 1,003 | 1,073 | 1,275 | 1,427 | 1,466 | 1,874 | 2,279 | 2,202 | 2,381 | 2,660 | 2,805 |
| Fixed Assets | 251 | 274 | 227 | 296 | 352 | 462 | 472 | 741 | 959 | 914 | 933 | 953 | 1,052 |
| CWIP | 50 | 10 | 18 | 7 | 60 | 38 | 18 | 28 | 9 | 26 | 13 | 46 | 59 |
| Investments | 0 | 0 | 35 | 50 | 96 | 97 | 97 | 1 | 1 | 23 | 10 | 11 | 13 |
| Other Assets | 559 | 655 | 722 | 720 | 767 | 830 | 879 | 1,103 | 1,309 | 1,239 | 1,425 | 1,650 | 1,681 |
| Total Assets | 861 | 939 | 1,003 | 1,073 | 1,275 | 1,427 | 1,466 | 1,874 | 2,279 | 2,202 | 2,381 | 2,660 | 2,805 |
Below is a detailed analysis of the balance sheet data for S H Kelkar & Company Ltd (SHK) based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 138.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 138.00 Cr..
- For Reserves, as of Sep 2025, the value is 1,191.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,134.00 Cr. (Mar 2025) to 1,191.00 Cr., marking an increase of 57.00 Cr..
- For Borrowings, as of Sep 2025, the value is 889.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 832.00 Cr. (Mar 2025) to 889.00 Cr., marking an increase of 57.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 587.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 556.00 Cr. (Mar 2025) to 587.00 Cr., marking an increase of 31.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 2,805.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,660.00 Cr. (Mar 2025) to 2,805.00 Cr., marking an increase of 145.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 1,052.00 Cr.. The value appears strong and on an upward trend. It has increased from 953.00 Cr. (Mar 2025) to 1,052.00 Cr., marking an increase of 99.00 Cr..
- For CWIP, as of Sep 2025, the value is 59.00 Cr.. The value appears strong and on an upward trend. It has increased from 46.00 Cr. (Mar 2025) to 59.00 Cr., marking an increase of 13.00 Cr..
- For Investments, as of Sep 2025, the value is 13.00 Cr.. The value appears strong and on an upward trend. It has increased from 11.00 Cr. (Mar 2025) to 13.00 Cr., marking an increase of 2.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,681.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,650.00 Cr. (Mar 2025) to 1,681.00 Cr., marking an increase of 31.00 Cr..
- For Total Assets, as of Sep 2025, the value is 2,805.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,660.00 Cr. (Mar 2025) to 2,805.00 Cr., marking an increase of 145.00 Cr..
Notably, the Reserves (1,191.00 Cr.) exceed the Borrowings (889.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -80.00 | -133.00 | 66.00 | 93.00 | -13.00 | -201.00 | -205.00 | -279.00 | -483.00 | -403.00 | -362.00 | -536.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 86 | 85 | 90 | 81 | 99 | 99 | 104 | 103 | 108 | 95 | 97 | 87 |
| Inventory Days | 255 | 252 | 239 | 247 | 233 | 239 | 201 | 216 | 225 | 228 | 243 | 227 |
| Days Payable | 80 | 76 | 116 | 78 | 104 | 86 | 103 | 125 | 143 | 138 | 132 | 126 |
| Cash Conversion Cycle | 261 | 261 | 213 | 250 | 228 | 252 | 202 | 195 | 190 | 185 | 209 | 187 |
| Working Capital Days | 157 | 70 | 135 | 128 | 110 | 86 | 55 | 91 | 90 | 88 | 63 | 62 |
| ROCE % | 18% | 14% | 17% | 19% | 17% | 12% | 10% | 15% | 10% | 8% | 12% | 10% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Bandhan Small Cap Fund | 5,415,240 | 0.51 | 97.03 | 5,180,624 | 2026-01-26 07:17:42 | 4.53% |
| LIC MF Manufacturing Fund | 608,005 | 1.45 | 10.89 | N/A | N/A | N/A |
| LIC MF Small Cap Fund | 319,836 | 0.93 | 5.73 | N/A | N/A | N/A |
| LIC MF Balanced Advantage Fund | 303,558 | 0.73 | 5.44 | N/A | N/A | N/A |
| LIC MF Focused Fund | 301,129 | 3.13 | 5.4 | N/A | N/A | N/A |
| LIC MF Dividend Yield Fund | 294,810 | 0.77 | 5.28 | N/A | N/A | N/A |
| Quantum Small Cap Fund | 182,823 | 1.84 | 3.28 | N/A | N/A | N/A |
| Tata Childrens Fund | 150,000 | 0.74 | 2.69 | N/A | N/A | N/A |
| LIC MF Value Fund | 116,079 | 1.04 | 2.08 | 119,795 | 2026-01-26 07:17:42 | -3.1% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 5.31 | 8.93 | 4.53 | 10.81 | 10.48 |
| Diluted EPS (Rs.) | 5.31 | 8.93 | 4.53 | 10.81 | 10.48 |
| Cash EPS (Rs.) | 12.22 | 15.38 | 10.37 | 15.98 | 14.52 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 91.89 | 87.62 | 79.66 | 79.01 | 67.55 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 91.89 | 87.62 | 79.66 | 79.01 | 67.55 |
| Revenue From Operations / Share (Rs.) | 153.40 | 139.43 | 121.84 | 113.00 | 93.54 |
| PBDIT / Share (Rs.) | 23.18 | 22.60 | 16.55 | 16.77 | 18.35 |
| PBIT / Share (Rs.) | 16.34 | 16.15 | 10.74 | 11.59 | 14.00 |
| PBT / Share (Rs.) | 8.39 | 13.17 | 7.55 | 9.55 | 13.68 |
| Net Profit / Share (Rs.) | 5.37 | 8.93 | 4.56 | 10.79 | 10.17 |
| NP After MI And SOA / Share (Rs.) | 5.29 | 8.84 | 4.42 | 10.73 | 10.24 |
| PBDIT Margin (%) | 15.11 | 16.21 | 13.58 | 14.84 | 19.61 |
| PBIT Margin (%) | 10.65 | 11.58 | 8.81 | 10.25 | 14.96 |
| PBT Margin (%) | 5.47 | 9.44 | 6.19 | 8.45 | 14.62 |
| Net Profit Margin (%) | 3.50 | 6.40 | 3.74 | 9.55 | 10.87 |
| NP After MI And SOA Margin (%) | 3.44 | 6.34 | 3.62 | 9.49 | 10.94 |
| Return on Networth / Equity (%) | 5.75 | 10.09 | 5.74 | 14.66 | 15.20 |
| Return on Capital Employeed (%) | 14.55 | 15.22 | 9.82 | 10.20 | 14.93 |
| Return On Assets (%) | 2.72 | 5.09 | 2.75 | 6.46 | 7.62 |
| Long Term Debt / Equity (X) | 0.13 | 0.14 | 0.29 | 0.35 | 0.34 |
| Total Debt / Equity (X) | 0.58 | 0.50 | 0.53 | 0.62 | 0.51 |
| Asset Turnover Ratio (%) | 0.83 | 0.83 | 0.74 | 0.55 | 0.60 |
| Current Ratio (X) | 1.39 | 1.46 | 1.70 | 1.70 | 1.82 |
| Quick Ratio (X) | 0.75 | 0.75 | 0.85 | 0.93 | 1.07 |
| Inventory Turnover Ratio (X) | 3.09 | 3.06 | 1.72 | 1.58 | 1.82 |
| Dividend Payout Ratio (NP) (%) | 14.17 | 22.61 | 16.96 | 7.13 | 9.76 |
| Dividend Payout Ratio (CP) (%) | 6.18 | 13.07 | 7.32 | 4.81 | 6.85 |
| Earning Retention Ratio (%) | 85.83 | 77.39 | 83.04 | 92.87 | 90.24 |
| Cash Earning Retention Ratio (%) | 93.82 | 86.93 | 92.68 | 95.19 | 93.15 |
| Interest Coverage Ratio (X) | 6.49 | 7.58 | 9.59 | 14.35 | 15.19 |
| Interest Coverage Ratio (Post Tax) (X) | 3.75 | 3.99 | 4.49 | 10.97 | 8.69 |
| Enterprise Value (Cr.) | 3118.96 | 3356.30 | 1912.25 | 2576.78 | 1935.94 |
| EV / Net Operating Revenue (X) | 1.47 | 1.74 | 1.13 | 1.65 | 1.46 |
| EV / EBITDA (X) | 9.72 | 10.73 | 8.35 | 11.10 | 7.46 |
| MarketCap / Net Operating Revenue (X) | 1.16 | 1.47 | 0.81 | 1.27 | 1.19 |
| Retention Ratios (%) | 85.82 | 77.38 | 83.03 | 92.86 | 90.23 |
| Price / BV (X) | 1.93 | 2.34 | 1.29 | 1.96 | 1.66 |
| Price / Net Operating Revenue (X) | 1.16 | 1.47 | 0.81 | 1.27 | 1.19 |
| EarningsYield | 0.02 | 0.04 | 0.04 | 0.07 | 0.09 |
After reviewing the key financial ratios for S H Kelkar & Company Ltd (SHK), here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 5.31. This value is within the healthy range. It has decreased from 8.93 (Mar 24) to 5.31, marking a decrease of 3.62.
- For Diluted EPS (Rs.), as of Mar 25, the value is 5.31. This value is within the healthy range. It has decreased from 8.93 (Mar 24) to 5.31, marking a decrease of 3.62.
- For Cash EPS (Rs.), as of Mar 25, the value is 12.22. This value is within the healthy range. It has decreased from 15.38 (Mar 24) to 12.22, marking a decrease of 3.16.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 91.89. It has increased from 87.62 (Mar 24) to 91.89, marking an increase of 4.27.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 91.89. It has increased from 87.62 (Mar 24) to 91.89, marking an increase of 4.27.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 153.40. It has increased from 139.43 (Mar 24) to 153.40, marking an increase of 13.97.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 23.18. This value is within the healthy range. It has increased from 22.60 (Mar 24) to 23.18, marking an increase of 0.58.
- For PBIT / Share (Rs.), as of Mar 25, the value is 16.34. This value is within the healthy range. It has increased from 16.15 (Mar 24) to 16.34, marking an increase of 0.19.
- For PBT / Share (Rs.), as of Mar 25, the value is 8.39. This value is within the healthy range. It has decreased from 13.17 (Mar 24) to 8.39, marking a decrease of 4.78.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 5.37. This value is within the healthy range. It has decreased from 8.93 (Mar 24) to 5.37, marking a decrease of 3.56.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 5.29. This value is within the healthy range. It has decreased from 8.84 (Mar 24) to 5.29, marking a decrease of 3.55.
- For PBDIT Margin (%), as of Mar 25, the value is 15.11. This value is within the healthy range. It has decreased from 16.21 (Mar 24) to 15.11, marking a decrease of 1.10.
- For PBIT Margin (%), as of Mar 25, the value is 10.65. This value is within the healthy range. It has decreased from 11.58 (Mar 24) to 10.65, marking a decrease of 0.93.
- For PBT Margin (%), as of Mar 25, the value is 5.47. This value is below the healthy minimum of 10. It has decreased from 9.44 (Mar 24) to 5.47, marking a decrease of 3.97.
- For Net Profit Margin (%), as of Mar 25, the value is 3.50. This value is below the healthy minimum of 5. It has decreased from 6.40 (Mar 24) to 3.50, marking a decrease of 2.90.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 3.44. This value is below the healthy minimum of 8. It has decreased from 6.34 (Mar 24) to 3.44, marking a decrease of 2.90.
- For Return on Networth / Equity (%), as of Mar 25, the value is 5.75. This value is below the healthy minimum of 15. It has decreased from 10.09 (Mar 24) to 5.75, marking a decrease of 4.34.
- For Return on Capital Employeed (%), as of Mar 25, the value is 14.55. This value is within the healthy range. It has decreased from 15.22 (Mar 24) to 14.55, marking a decrease of 0.67.
- For Return On Assets (%), as of Mar 25, the value is 2.72. This value is below the healthy minimum of 5. It has decreased from 5.09 (Mar 24) to 2.72, marking a decrease of 2.37.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.13. This value is below the healthy minimum of 0.2. It has decreased from 0.14 (Mar 24) to 0.13, marking a decrease of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.58. This value is within the healthy range. It has increased from 0.50 (Mar 24) to 0.58, marking an increase of 0.08.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.83. There is no change compared to the previous period (Mar 24) which recorded 0.83.
- For Current Ratio (X), as of Mar 25, the value is 1.39. This value is below the healthy minimum of 1.5. It has decreased from 1.46 (Mar 24) to 1.39, marking a decrease of 0.07.
- For Quick Ratio (X), as of Mar 25, the value is 0.75. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.75.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.09. This value is below the healthy minimum of 4. It has increased from 3.06 (Mar 24) to 3.09, marking an increase of 0.03.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 14.17. This value is below the healthy minimum of 20. It has decreased from 22.61 (Mar 24) to 14.17, marking a decrease of 8.44.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 6.18. This value is below the healthy minimum of 20. It has decreased from 13.07 (Mar 24) to 6.18, marking a decrease of 6.89.
- For Earning Retention Ratio (%), as of Mar 25, the value is 85.83. This value exceeds the healthy maximum of 70. It has increased from 77.39 (Mar 24) to 85.83, marking an increase of 8.44.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 93.82. This value exceeds the healthy maximum of 70. It has increased from 86.93 (Mar 24) to 93.82, marking an increase of 6.89.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 6.49. This value is within the healthy range. It has decreased from 7.58 (Mar 24) to 6.49, marking a decrease of 1.09.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.75. This value is within the healthy range. It has decreased from 3.99 (Mar 24) to 3.75, marking a decrease of 0.24.
- For Enterprise Value (Cr.), as of Mar 25, the value is 3,118.96. It has decreased from 3,356.30 (Mar 24) to 3,118.96, marking a decrease of 237.34.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.47. This value is within the healthy range. It has decreased from 1.74 (Mar 24) to 1.47, marking a decrease of 0.27.
- For EV / EBITDA (X), as of Mar 25, the value is 9.72. This value is within the healthy range. It has decreased from 10.73 (Mar 24) to 9.72, marking a decrease of 1.01.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.16. This value is within the healthy range. It has decreased from 1.47 (Mar 24) to 1.16, marking a decrease of 0.31.
- For Retention Ratios (%), as of Mar 25, the value is 85.82. This value exceeds the healthy maximum of 70. It has increased from 77.38 (Mar 24) to 85.82, marking an increase of 8.44.
- For Price / BV (X), as of Mar 25, the value is 1.93. This value is within the healthy range. It has decreased from 2.34 (Mar 24) to 1.93, marking a decrease of 0.41.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.16. This value is within the healthy range. It has decreased from 1.47 (Mar 24) to 1.16, marking a decrease of 0.31.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.04 (Mar 24) to 0.02, marking a decrease of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in S H Kelkar & Company Ltd (SHK):
- Net Profit Margin: 3.5%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 14.55% (Industry Average ROCE: 10.57%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 5.75% (Industry Average ROE: 8.89%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 3.75
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.75
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 26.1 (Industry average Stock P/E: 31.28)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.58
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 3.5%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Personal Care | Devkaran Mansion, Mumbai Maharashtra 400002 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ramesh Vaze | Chairman & Non-Exe.Director |
| Mr. Kedar Vaze | WholeTime Director & Group CEO |
| Mrs. Prabha Vaze | Non Executive Director |
| Mr. Deepak Raj Bindra | Independent Director |
| Mr. Shrikant Oka | Independent Director |
| Mr. Vasant Gujarathi | Independent Director |
| Ms. Neela Bhattacherjee | Independent Director |
FAQ
What is the intrinsic value of S H Kelkar & Company Ltd (SHK)?
S H Kelkar & Company Ltd (SHK)'s intrinsic value (as of 13 February 2026) is ₹156.70 which is 10.46% lower the current market price of ₹175.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹2,420 Cr. market cap, FY2025-2026 high/low of ₹276/135, reserves of ₹1,191 Cr, and liabilities of ₹2,805 Cr.
What is the Market Cap of S H Kelkar & Company Ltd (SHK)?
The Market Cap of S H Kelkar & Company Ltd (SHK) is 2,420 Cr..
What is the current Stock Price of S H Kelkar & Company Ltd (SHK) as on 13 February 2026?
The current stock price of S H Kelkar & Company Ltd (SHK) as on 13 February 2026 is ₹175.
What is the High / Low of S H Kelkar & Company Ltd (SHK) stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of S H Kelkar & Company Ltd (SHK) stocks is ₹276/135.
What is the Stock P/E of S H Kelkar & Company Ltd (SHK)?
The Stock P/E of S H Kelkar & Company Ltd (SHK) is 26.1.
What is the Book Value of S H Kelkar & Company Ltd (SHK)?
The Book Value of S H Kelkar & Company Ltd (SHK) is 96.1.
What is the Dividend Yield of S H Kelkar & Company Ltd (SHK)?
The Dividend Yield of S H Kelkar & Company Ltd (SHK) is 0.57 %.
What is the ROCE of S H Kelkar & Company Ltd (SHK)?
The ROCE of S H Kelkar & Company Ltd (SHK) is 10.3 %.
What is the ROE of S H Kelkar & Company Ltd (SHK)?
The ROE of S H Kelkar & Company Ltd (SHK) is 7.70 %.
What is the Face Value of S H Kelkar & Company Ltd (SHK)?
The Face Value of S H Kelkar & Company Ltd (SHK) is 10.0.